# FDA Inspection 1093250 - Zhejiang Huahai Pharmaceutical Co., Ltd. - May 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/2b5b7233-044f-42f2-ac3f-00e6696bfc49
Source feed: FDA_Inspections

> FDA Inspection 1093250 for Zhejiang Huahai Pharmaceutical Co., Ltd. on May 31, 2019. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093250
- Company Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- Inspection Date: 2019-05-31
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259818 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/92f6b7e9-21eb-46cb-8fa3-4bd171eb6e41)
- [FDA Inspection 1259818 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/6c8aed33-ef33-4a48-97c2-992934935373)
- [FDA Inspection 1149252 - 2021-07-02](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/819ef1a0-aa32-4708-bc0f-a8399a97fb40)
- [FDA Inspection 993041 - 2016-11-18](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/0b357083-d8c1-4b5b-9169-ab1f1c610575)
- [FDA Inspection 921574 - 2015-03-27](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/98610561-1547-4923-aaf6-de97c6883bb5)

Company: https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c